LAG3 and lung cancer: SPECT/CT imaging of lung cancers with 99mTc‐HYNIC‐αLAG‐3 and 99mTc‐HYNIC‐αPD‐L1 probes represents an effective method for noninvasively visualizing human LAG‐3 and PD‐L1, as well as immunotherapy resistance monitoring.